Cannabis use could double risk of heart deaths, study suggests
Cannabis use may double the risk of dying from heart disease and increase the risk of stroke by 20%, according to a global review of data.
The number of people using cannabis and cannabinoids has soared over the past decade. While previous studies have linked cannabis use to cardiovascular problems, the scale of the risk has until now not been clear.
This is an important gap in light of major changes in consumption, researchers at the University of Toulouse in France said.
To strengthen the evidence base, they searched databases looking for large observational studies, published between 2016 and 2023, which explored cannabis use and cardiovascular outcomes.
Twenty-four studies, involving about 200 million people, were included in a pooled data analysis of the results: 17 cross-sectional studies, six cohort studies, and one case-control study.
Study participants were mostly aged between 19 and 59. And in those studies where sex was recorded, cannabis users tended to be mostly male and younger than non-users.
The analysis revealed heightened risks for cannabis use: 29% higher for acute coronary syndrome; 20% higher for stroke; and a doubling in the risk of dying from cardiovascular disease. The findings were published in the journal Heart.
The researchers acknowledged several limitations to their systematic review and meta analysis. There was a moderate to high risk of bias in most of the included studies, largely because of lack of information on missing data and imprecise measures of cannabis exposure. Most of them were observational and several used the same data.
Sign up to Headlines UK
Get the day's headlines and highlights emailed direct to you every morning
after newsletter promotion
With these caveats, the researchers said their work was an exhaustive analysis of published data on the potential association between cannabis use and major cardiovascular disease and provided new insights from real-world data. 'The findings outlined by this meta analysis should enhance the general awareness of the potential of cannabis to cause cardiovascular harm.'
In a linked editorial, Prof Stanton Glantz and Dr Lynn Silver of the University of California at San Francisco said the analysis 'raises serious questions about the assumption that cannabis imposes little cardiovascular risk'.
More research is needed to clarify whether cardiovascular risks are limited to inhaled products or extend to other forms of cannabis exposure, they said. Cannabis is now generally more potent and has diversified into a wide array of inhaled high potency cannabis concentrates, synthetic psychoactive cannabinoids, and edibles, they added.
They wrote: 'How these changes affect cardiovascular risk requires clarification, as does the proportion of risk attributable to cannabinoids themselves versus particulate matter, terpenes or other components of the exposure.
'Cannabis needs to be incorporated into the framework for prevention of clinical cardiovascular disease. So too must cardiovascular disease prevention be incorporated into the regulation of cannabis markets. Effective product warnings and education on risks must be developed, required, and implemented.
'Cardiovascular and other health risks must be considered in the regulation of allowable product and marketing design as the evidence base grows. Today that regulation is focused on establishing the legal market with woeful neglect of minimising health risks.
'Specifically, cannabis should be treated like tobacco: not criminalised, but discouraged, with protection of bystanders from secondhand exposure.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
5 hours ago
- Daily Mail
GPs to hunt patients with 'red flag' risk factor for lethal pancreatic cancer - are YOU on the list?
Health chiefs are set to introduce a groundbreaking screening scheme that aims to offer long-awaited hope for those who develop the UK's most lethal cancer. Pancreatic cancer—dubbed a 'silent killer' due to its subtle symptoms—kills just over 10,000 patients every year, about one death every hour. It is typically diagnosed at late stages, as warning signs are easily mistaken for other problems. But now, GP clinics will contact patients believed to be at high-risk of the disease, and call them in for urgent tests, in the hope of pre-empting symptoms. Those considered at danger of developing the illness are the over 60s with a recent diagnosis of diabetes or sudden weight loss. Despite numerous breakthroughs for other forms of the disease that are helping patients live longer, the outlook for pancreatic cancer patients remains shockingly dismal. Just one in 20 of those diagnosed with the disease are expected to live to see the next decade, with more than half dying within just three months. The new NHS pilot, involving more than 300 GP practices in England, aims to find patients at the earliest, most treatable stages of the disease. Health service officials hope the £2million project, which will be in full swing this autumn, will result in at least 300 earlier diagnoses. Currently only about one in five pancreatic cancer patients are diagnosed in the early stages of the disease when treatment has the greatest chance of success. Medics will specifically look for recent cases of diabetes due to data suggesting about half of pancreatic cancer patients are diagnosed with the blood sugar condition shortly before they are found to have the disease. This is because the cancer destroys the same insulin-producing cells in the pancreas—which help control blood sugar—that are also destroyed in diabetes. These patients will be called in for urgent blood tests and medical scans. If pancreatic cancer is spotted early, before it spreads throughout the body, about half of patients will survive at least a year. But if cancer has already spread beyond the organ—as happens for the majority of patients— only one in 10 patients will survive a year. Professor Peter Johnson, NHS national clinical director for cancer, said: 'Pancreatic cancer is responsible for so many deaths because patients don't usually notice symptoms until the cancer is at an advanced stage, which is why we need to find new ways to pick it up. 'If your GP practice identifies you as at risk of pancreatic cancer, I urge you to come forward for testing as soon as possible.' Health minister Karin Smyth added: 'This targeted approach to identify people at risk of one of the most lethal cancers could give more people a fighting chance and spare the heartbreak of countless families.' Alfie Bailey-Bearfield, head of influencing and health improvement at Pancreatic Cancer UK, said: 'Many of the people who are referred for a CT scan during the pilot will not have pancreatic cancer, but for those that do, the impact could be lifesaving. 'Subject to the pilot's success, we will be calling for this pilot to be expanded across the country to help give more people affected by the deadliest common cancer the very best chance of survival.' Previous research has shown that people over 50 with a new case of type 2 diabetes have a higher chance of being diagnosed with pancreatic cancer within three years. While pancreatic cancer is most likely to strike people over the age 75—with 47 per cent of all cases in this demographic—younger groups can also get the disease. Last year MailOnline highlighted a 'frightening' explosion of young women developing the disease. Rates of pancreatic cancer have soared by up to 200 per cent in women under the age of 25 since the 1990s. While numbers remain low, oncologists cannot explain the surge in young women, with no such spike noted in men of the same age. Overall, incidences of the disease have increased by around 17 per cent in Britain over the same timespan, with soaring obesity rates suspected to be behind the trend. A number of celebrity diagnoses in recent years have thrown pancreatic cancer into the spotlight. Last year former England manager Sven-Goran Eriksson, 76, died after a battle with the disease. Other famous victims include legendary actors Patrick Swayze and Alan Rickman as well as Apple's iconic founder Steve Jobs and The Smiths bassist Andy Rourke. Potential symptoms of pancreatic cancer include jaundice, where the whites of the eyes and skin turn a yellow hue, alongside itchy skin and darker urine. Other possible signs include loss of appetite, unintended weight loss, constipation or bloating. While these symptoms are unlikely to be cancer it is important that they are checked out by a GP early just in case, especially if people have had them for over four weeks. The pancreas is a tadpole-shaped organ that forms part of the digestive system and also performs a crucial role in hormone regulation. It is located just behind the stomach and is about 25cm in length. In its digestive role, it helps produce enzymes that help the body break down food into the nutrients it needs. It is also critical in making hormones responsible for controlling blood sugar levels in the body. Charity, Cancer Research UK, estimates 22 per cent of cases of the disease are caused by smoking and 12 per cent by obesity.
The Guardian
5 hours ago
- The Guardian
Overseas-trained dentists working in McDonald's as millions lack NHS care
Overseas-trained dentists are working in McDonald's and other takeaways in the UK even though millions of patients are finding it impossible to get NHS dental care. The disclosure comes in a new report being sent to MPs on Wednesday, which urges ministers to slash bureaucracy stopping dentists from abroad plugging the huge gaps in NHS dental care. The main obstacle they face is securing a place to take the exams needed to work in the UK, a process so difficult some liken it to obtaining a ticket to see Taylor Swift. As a result fully qualified dentists from countries such as India, Egypt and Albania are spending months or even years at a time working in fast food cafes, according to the Association of Dental Groups (ADG). The ADG, which represents major dental providers, demanded an urgent overhaul of the two-part overseas registration examination (ORE) to avoid 'an unacceptable waste' of foreign dentists' skills. Dentists who qualified overseas need to pass both parts of the ORE in order to gain entry to the General Dental Council's register, which then allows them to work in the UK. 'It is a shameful waste to have them flipping burgers in our fast food restaurants when they could be caring for patients,' said Neil Carmichael, the ADG's executive chair. 'The fact that at the ADG we have been talking to dentists who are having to take unskilled jobs in fast food restaurants for months or even years after arriving in the UK is an unacceptable waste of their skills – and a disservice to the patients who need to see a dentist. 'We can't tolerate more stories about desperate patients resorting to pulling their own teeth out whilst we have qualified dentists here, fully trained and ready to help – yet not able to use their skills.' There are 6,000 overseas-qualified dentists waiting to take the exams, GDC figures show. But only 600 people can sit the exam, which the GDC usually organises twice a year, though the body has put on extra sittings in recent months to try to tackle the backlog. At the same time the NHS in England had 2,749 vacancies for dentists in 2023-24 and 4.5 million people in England alone currently cannot access NHS dental care. About one in four of all dentists in the UK qualified abroad, GDC data shows. Ahmed, an overseas-trained dentist from Egypt, works both in McDonald's and part-time as a dental nurse. 'Despite holding a postgraduate masters degree in dental implantology and being a fully qualified Egyptian dentist, I am currently working at McDonald's,' he said. 'I am frustrated at the ORE system and have been trying since 2022 to complete the GDC registration to practice here in the UK.' Shoaib Saiyed, who is also struggling to get a place to do the ORE, said: 'I am a fully trained dentist from India with 10 years experience but right now my title is 'sandwich artist'. I have been making sandwiches at a Subway fast food outlet in Birmingham for over nine months.' Sayed Bilal Bukhara, another dentist from India, works in a care home and also as a dental hygienist. He added: 'Once the ORE places open up on the system they are gone in just two minutes. A couple of my friends in the situation have given up and moved to Dubai.' Mark Dayan, an expert in dental care at the Nuffield Trust thinktank, said: 'Barriers to overseas recruitment aren't the only reason patients can't get an appointment. Our creaking NHS system does a bad job of attracting the dentists who are already working here, with many preferring to practice privately. 'But delays in the registration process for foreign recruits are something of an unforced error, stopping us from the kind of sharp expansion we have recently seen in so many other professions.' The Department of Health and Social Care said: 'This government inherited a broken NHS dental system but we are getting on with fixing it through a strengthened workforce and the upcoming 10-year health plan. 'We've already begun the rollout of 700,000 extra urgent dental appointments, a 'golden hello' scheme is under way to recruit dentists to areas with the most need and we are reforming the NHS dental contract, with a shift to focus on prevention and the retention of NHS dentists.'
The Guardian
5 hours ago
- The Guardian
Cannabis use could double risk of heart deaths, study suggests
Cannabis use may double the risk of dying from heart disease and increase the risk of stroke by 20%, according to a global review of data. The number of people using cannabis and cannabinoids has soared over the past decade. While previous studies have linked cannabis use to cardiovascular problems, the scale of the risk has until now not been clear. This is an important gap in light of major changes in consumption, researchers at the University of Toulouse in France said. To strengthen the evidence base, they searched databases looking for large observational studies, published between 2016 and 2023, which explored cannabis use and cardiovascular outcomes. Twenty-four studies, involving about 200 million people, were included in a pooled data analysis of the results: 17 cross-sectional studies, six cohort studies, and one case-control study. Study participants were mostly aged between 19 and 59. And in those studies where sex was recorded, cannabis users tended to be mostly male and younger than non-users. The analysis revealed heightened risks for cannabis use: 29% higher for acute coronary syndrome; 20% higher for stroke; and a doubling in the risk of dying from cardiovascular disease. The findings were published in the journal Heart. The researchers acknowledged several limitations to their systematic review and meta analysis. There was a moderate to high risk of bias in most of the included studies, largely because of lack of information on missing data and imprecise measures of cannabis exposure. Most of them were observational and several used the same data. Sign up to Headlines UK Get the day's headlines and highlights emailed direct to you every morning after newsletter promotion With these caveats, the researchers said their work was an exhaustive analysis of published data on the potential association between cannabis use and major cardiovascular disease and provided new insights from real-world data. 'The findings outlined by this meta analysis should enhance the general awareness of the potential of cannabis to cause cardiovascular harm.' In a linked editorial, Prof Stanton Glantz and Dr Lynn Silver of the University of California at San Francisco said the analysis 'raises serious questions about the assumption that cannabis imposes little cardiovascular risk'. More research is needed to clarify whether cardiovascular risks are limited to inhaled products or extend to other forms of cannabis exposure, they said. Cannabis is now generally more potent and has diversified into a wide array of inhaled high potency cannabis concentrates, synthetic psychoactive cannabinoids, and edibles, they added. They wrote: 'How these changes affect cardiovascular risk requires clarification, as does the proportion of risk attributable to cannabinoids themselves versus particulate matter, terpenes or other components of the exposure. 'Cannabis needs to be incorporated into the framework for prevention of clinical cardiovascular disease. So too must cardiovascular disease prevention be incorporated into the regulation of cannabis markets. Effective product warnings and education on risks must be developed, required, and implemented. 'Cardiovascular and other health risks must be considered in the regulation of allowable product and marketing design as the evidence base grows. Today that regulation is focused on establishing the legal market with woeful neglect of minimising health risks. 'Specifically, cannabis should be treated like tobacco: not criminalised, but discouraged, with protection of bystanders from secondhand exposure.'
